Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 2
2001 2
2005 1
2006 2
2007 1
2008 2
2010 3
2011 1
2012 2
2013 3
2014 5
2015 1
2016 1
2017 2
2018 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma.
Zeinali M, Adelinik A, Papian S, Khorramdelazad H, Abedinzadeh M. Zeinali M, et al. Hum Immunol. 2015 Oct;76(10):770-4. doi: 10.1016/j.humimm.2015.09.036. Epub 2015 Sep 30. Hum Immunol. 2015. PMID: 26429330 Review.
Changes in galectin-3 expression are commonly seen in cancerous and pre-cancerous conditions and galectin-3 may be involved in the regulation of cancer cell activities that contribute to tumourigenesis, cancer progression and metastasis. ...This review …
Changes in galectin-3 expression are commonly seen in cancerous and pre-cancerous conditions and galectin-3 may …
Modified citrus pectin inhibited bladder tumor growth through downregulation of galectin-3.
Fang T, Liu DD, Ning HM, Dan Liu, Sun JY, Huang XJ, Dong Y, Geng MY, Yun SF, Yan J, Huang RM. Fang T, et al. Acta Pharmacol Sin. 2018 Dec;39(12):1885-1893. doi: 10.1038/s41401-018-0004-z. Epub 2018 May 16. Acta Pharmacol Sin. 2018. PMID: 29769742 Free PMC article.
We further explored the possible molecular mechanisms upon MCP treatment in UBC cells. Reduction of galectin-3 was observed and followed with the inactivation of Akt signaling pathway. Of note, galectin-3 knockdown by RNA interference recapitulated the …
We further explored the possible molecular mechanisms upon MCP treatment in UBC cells. Reduction of galectin-3 was observed an …
Galectin-3 expression is associated with bladder cancer progression and clinical outcome.
Canesin G, Gonzalez-Peramato P, Palou J, Urrutia M, Cordón-Cardo C, Sánchez-Carbayo M. Canesin G, et al. Tumour Biol. 2010 Aug;31(4):277-85. doi: 10.1007/s13277-010-0033-9. Epub 2010 Apr 17. Tumour Biol. 2010. PMID: 20401558
Galectin-3 protein levels were then quantified in 160 urinary specimens of bladder cancer patients and controls by enzymeimmunoanalysis. ...Furthermore, galectin-3 urinary levels segregated bladder cancer patients from contr
Galectin-3 protein levels were then quantified in 160 urinary specimens of bladder cancer patients and controls
Galectin 3 for the diagnosis of bladder cancer.
El Gendy H, Madkour B, Abdelaty S, Essawy F, Khattab D, Hammam O, El Kholy A, Nour HH. El Gendy H, et al. Arab J Urol. 2014 Jun;12(2):178-81. doi: 10.1016/j.aju.2013.10.004. Epub 2013 Nov 20. Arab J Urol. 2014. PMID: 26019945 Free PMC article.
OBJECTIVE: To evaluate serum levels of galectin-3 (G-3) in patients with bladder cancer and a control group, as a potential diagnostic and prognostic serum tumour marker. ...CONCLUSIONS: The level of G-3 can aid as a diagnostic marker in patient …
OBJECTIVE: To evaluate serum levels of galectin-3 (G-3) in patients with bladder cancer and a control group, as …
Urinary IL-33 and galectin-3 increase in patients with interstitial cystitis/bladder pain syndrome (review).
Kochiashvili G, Kochiashvili D. Kochiashvili G, et al. Georgian Med News. 2014 Jul-Aug;(232-233):12-5. Georgian Med News. 2014. PMID: 25214264 Review.
Interstitial cystitis/bladder pain syndrome (IC/BPS) is an enigmatic chronic disorder characterized by vague bladder pain of variable severity accompanied by urinary symptoms. ...Urinary IL-33, and Gal-3 levels were normalized by urinary
Interstitial cystitis/bladder pain syndrome (IC/BPS) is an enigmatic chronic disorder characterized by vague bladder pain of v …
Galectin-3 interactions with glycosphingolipids.
Collins PM, Bum-Erdene K, Yu X, Blanchard H. Collins PM, et al. J Mol Biol. 2014 Apr 3;426(7):1439-51. doi: 10.1016/j.jmb.2013.12.004. Epub 2013 Dec 8. J Mol Biol. 2014. PMID: 24326249
LNnT also presents an important model for poly-N-acetyllactosamine-containing glycans and provides insight into galectin-3's accommodation of extended oligosaccharides such as the poly-N-acetyllactosamine-modified N- and O-glycans that, via galectin- …
LNnT also presents an important model for poly-N-acetyllactosamine-containing glycans and provides insight into galectin-3' …
Serum level of galectin-3 in human bladder cancer.
Sakaki M, Oka N, Nakanishi R, Yamaguchi K, Fukumori T, Kanayama HO. Sakaki M, et al. J Med Invest. 2008 Feb;55(1-2):127-32. doi: 10.2152/jmi.55.127. J Med Invest. 2008. PMID: 18319555 Free article.
Higher expression of galectin-3 was observed in bladder cancer tissue than in normal bladder tissue. We suggest the measurement of serum galectin-3 is useful for diagnosis of bladder cancer....
Higher expression of galectin-3 was observed in bladder cancer tissue than in normal bladder tissue. We suggest …
Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancer.
Kramer MW, Kuczyk MA, Hennenlotter J, Serth J, Schilling D, Stenzl A, Merseburger AS. Kramer MW, et al. Oncol Rep. 2008 Dec;20(6):1403-8. Oncol Rep. 2008. PMID: 19020721
Galectin-3 (gal-3) is a glycoprotein involved in various physiological cellular processes. ...The aim of the present investigation was to elucidate the role of galectin-3 in the development and/or progression of non-muscle invasive (pTa, pT1) tr
Galectin-3 (gal-3) is a glycoprotein involved in various physiological cellular processes. ...The aim of the present in
galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas.
Cindolo L, Benvenuto G, Salvatore P, Pero R, Salvatore G, Mirone V, Prezioso D, Altieri V, Bruni CB, Chiariotti L. Cindolo L, et al. Int J Cancer. 1999 Feb 19;84(1):39-43. doi: 10.1002/(sici)1097-0215(19990219)84:1<39::aid-ijc8>3.0.co;2-e. Int J Cancer. 1999. PMID: 9988230 Free article.
Galectin-1 and galectin-3 are galactoside-binding proteins involved in different steps of tumor progression and potential targets for therapy. ...Galectin-1 mRNA levels were highly increased in most high-grade tumors compared with normal bladder
Galectin-1 and galectin-3 are galactoside-binding proteins involved in different steps of tumor progression and potenti
Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
Oka N, Nakahara S, Takenaka Y, Fukumori T, Hogan V, Kanayama HO, Yanagawa T, Raz A. Oka N, et al. Cancer Res. 2005 Sep 1;65(17):7546-53. doi: 10.1158/0008-5472.CAN-05-1197. Cancer Res. 2005. PMID: 16140916 Free article.
Here, we question the generality of the phenomenon by studying a different member of this family of proteins [e.g., TNF-related apoptosis-inducing ligand (TRAIL), which induces apoptosis in a wide variety of cancer cells]. Overexpression of galectin-3 in J82 human …
Here, we question the generality of the phenomenon by studying a different member of this family of proteins [e.g., TNF-related apoptosis-in …
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page